News Quantified

ATRC – atricure, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference

AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.

AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human Success - Has The Bull Case Changed? [Yahoo! Finance]

AtriCure Announces the First Patients Treated with Novel Dual Energy Platform

Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]

-3.8%

BEAT

10.7%

BEAT

-13.7%

BEAT

-6.5%

MISS

Canaccord Genuity

Market Outperform

Market Outperform

Form 4 AtriCure, Inc. For: Dec 10 Filed by: CARREL MICHAEL H

Form 4 AtriCure, Inc. For: Nov 24 Filed by: WEHRWEIN SVEN

Form 4 AtriCure, Inc. For: Nov 26 Filed by: Noznesky Justin J

Form 144 AtriCure, Inc. Filed by: Noznesky Justin J

Form 144 AtriCure, Inc. Filed by: WEHRWEIN SVEN

Top News Gainers

4/8 Form DEF 14A AtriCure, Inc. For: Apr 08 14.3%

4/7 AtriCure Inc. (NASDAQ: ATRC) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $45.00 price target on the stock. 7.5%

4/29 Form 4 AtriCure, Inc. For: Apr 27 Filed by: Lanning Mark R 5.1%

4/9 AtriCure pulls FY 2020 guidance amid COVID-19 [Seeking Alpha] 4.5%

12/5 Form 4 AtriCure, Inc. For: Dec 04 Filed by: Florin Daniel P 4.5%

4/30 AtriCure, Inc. (ATRC) CEO Michael Carrel on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] 4.3%

1/17 Form 4 AtriCure, Inc. For: Jan 15 Filed by: Collar Mark A 4.1%

1/16 Form 4 AtriCure, Inc. For: Jan 14 Filed by: CARREL MICHAEL H 4.1%

1/27 Form SC 13G/A AtriCure, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP 3.2%

4/10 Form SC 13G/A AtriCure, Inc. Filed by: FMR LLC 3.0%

Top News Decliners

3/14 AtriCure Inc. (NASDAQ: ATRC) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -17.0%

8/13 AtriCure Inc. (NASDAQ: ATRC) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. -5.2%

8/2 Form 4 AtriCure, Inc. For: Jul 31 Filed by: CARREL MICHAEL H -4.3%

8/13 AtriCure To Acquire SentreHEART For Atrial Fib Tech [Seeking Alpha] -4.2%

2/21 AtriCure Inc. (NASDAQ: ATRC) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -3.7%

4/1 AtriCure Inc. (NASDAQ: ATRC) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -3.6%

1/31 Form 4 AtriCure, Inc. For: Jan 29 Filed by: Seith Douglas J -3.6%

2/19 AtriCure Inc. (NASDAQ: ATRC) had its price target raised by analysts at Piper Sandler from to . -3.5%

6/25 AtriCure Inc. (NASDAQ: ATRC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $35.00 price target on the stock. -3.4%

4/15 AtriCure to Announce First Quarter 2020 Financial Results -3.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day